Announcements Trials
Browse Landscape

Phase

Phase 2 6Phase 3 4Phase 4 2Phase NA 1Phase 2/3 1

Status

Completed 11Unknown 4Recruiting 3Active not recruiting 2Terminated 1Not yet recruiting 1

Sponsor Class

OTHER 3NIH 1

Study Type

Interventional 4

Sponsor

Cancer Type

Breast 4

Conditions

Breast Neoplasms 4

Interventions

Cisplatin 130Radiotherapy 94Carboplatin 85Paclitaxel 78Fluorouracil 78Cyclophosphamide 77Gemcitabine 72Capecitabine 66Docetaxel 65Doxorubicin 60Oxaliplatin 59Etoposide 57Leucovorin 49Vincristine 47Chemotherapy, Adjuvant 42Cytarabine 38Dexamethasone 35Drug Therapy 33Bevacizumab 30Epirubicin 29Neoadjuvant Therapy 28Pemetrexed 27Tamoxifen 25Prednisone 24Irinotecan 24Rituximab 21Methotrexate 21Radiotherapy, Intensity-Modulated 19apatinib 18Vinorelbine 18

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 3 × Unknown × Aromatase Inhibitors × Clear all
NCT02914158 2023-01-17

ASPAIT

First Affiliated Hospital, Sun Yat-Sen University

Phase 3 Unknown
680 enrolled
Breast

Breast Neoplasms

NCT02769104 2018-01-09

ACCN

Zhejiang Cancer Hospital

Phase 3 Unknown
120 enrolled
Breast

Breast Neoplasms

NCT02394496 2016-06-15

OVER

Consorzio Oncotech

Phase 3 Unknown
396 enrolled
Breast

Breast Neoplasms

NCT00629278 2013-08-07

Combination Chemotherapy and Trastuzumab in Treating Women With Stage I, Stage II, or Stage III HER2-Positive Breast Cancer

National Cancer Institute (NCI)

Phase 3 Unknown
2,500 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡